Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation

Objectives: To assess the clinical effectiveness and cost-effectiveness of deferasirox for the treatment of iron overload associated with regular blood transfusions in patients with chronic anaemia such as beta-thalassaemia major (beta-TM) and sickle cell disease (SCD). Data sources: Electronic data...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: C McLeod, N Fleeman, J Kirkham, A Bagust, A Boland, P Chu, R Dickson, Y Dundar, J Greenhalgh, B Modell, A Olujohungbe, P Telfer, T Walley
Format: Artigo
Jezik:Inglês
Izdano: NIHR Journals Library 2009-01-01
Serija:Health Technology Assessment
Teme:
deferasirox
iron-overload
sickle-cell-disease
beta-thalassaemia
transfusionalhaemosiderosis
iron-chelating-agent
Online pristup:https://doi.org/10.3310/hta13010
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items